• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CME Group Inc. Reports All-Time Record Revenue of $1.5 Billion for Q2 2024

    7/24/24 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    • Record quarterly adjusted net income and earnings per share
    • Highest Q2 average daily volume (ADV) in company history (26 million contracts)
    • Year-over-year growth across every asset class

    CHICAGO, July 24, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2024.

    The company reported revenue of $1.5 billion and operating income of $1.0 billion for the second quarter of 2024. Net income was $883 million and diluted earnings per common share were $2.42. On an adjusted basis, net income was $932 million and diluted earnings per common share were $2.56. Financial results presented on an adjusted basis for the second quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

    "As escalating uncertainties drove an increased need for risk management across all asset classes, CME Group achieved record Q2 volume and generated record revenue, adjusted net income and adjusted earnings per share," said CME Group Chairman and Chief Executive Officer Terry Duffy. "During the quarter, and for the first time in more than a decade, our volume and open interest grew in every asset class, with overall ADV up 16% in commodities and 13% in financial markets. We also reached significant records in many of our U.S. Treasury products where ADV increased 36% to 8.2 million contracts."

    "As we move through the remainder of 2024, we will continue to focus on delivering capital efficiencies, bringing new products to market and creating additional value for our clients through our partnership with Google Cloud."

    Second-quarter 2024 average daily volume (ADV) was 25.9 million contracts, including non-U.S. ADV, which reached a record 7.8 million contracts.

    1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

    Clearing and transaction fees revenue for second-quarter 2024 totaled $1.2 billion. The total average rate per contract was $0.708. Market data revenue totaled $175 million for second-quarter 2024.

    As of June 30, 2024, the company had approximately $2.0 billion in cash (including $225 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the second quarter of approximately $419 million. The company has returned approximately $25.2 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

    CME Group will hold a Q&A conference call to discuss second-quarter 2024 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

    As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

    CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

    Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners' actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC") on February 28, 2024, under the caption "Risk Factors".

    CME Group Inc. and Subsidiaries

    Consolidated Balance Sheets

    (in millions)







    June 30, 2024



    December 31, 2023

    ASSETS









    Current Assets:









    Cash and cash equivalents



    $                 1,789.9



    $                2,912.0

    Marketable securities



    121.7



    111.7

    Accounts receivable, net of allowance



    599.5



    535.6

    Other current assets (includes $5.2 in restricted cash)



    567.5



    1,138.4

    Performance bonds and guaranty fund contributions



    85,670.0



    90,192.5

    Total current assets



    88,748.6



    94,890.2

    Property, net of accumulated depreciation and amortization



    384.5



    409.5

    Intangible assets—trading products



    17,175.3



    17,175.3

    Intangible assets—other, net



    2,932.5



    3,050.2

    Goodwill



    10,488.6



    10,495.3

    Other assets



    3,649.8



    3,685.6

    Total Assets



    $             123,379.3



    $             129,706.1

    LIABILITIES AND EQUITY









    Current Liabilities:









    Accounts payable



    $                      99.9



    $                      90.6

    Short-term debt



    749.5



    —

    Other current liabilities



    454.6



    3,133.8

    Performance bonds and guaranty fund contributions



    85,670.0



    90,192.5

    Total current liabilities



    86,974.0



    93,416.9

    Long-term debt



    2,677.2



    3,425.4

    Deferred income tax liabilities, net



    5,309.1



    5,327.7

    Other liabilities



    783.2



    798.2

    Total Liabilities



    95,743.5



    102,968.2

    Total CME Group Shareholders' Equity



    27,635.8



    26,737.9

    Total Liabilities and Equity



    $             123,379.3



    $            129,706.1

     

    CME Group Inc. and Subsidiaries

    Consolidated Statements of Income

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended

    June 30,



    Six Months Ended

    June 30,





    2024



    2023



    2024



    2023

    Revenues

















    Clearing and transaction fees



    $   1,249.9



    $   1,118.3



    $  2,458.8



    $  2,318.5

    Market data and information services



    175.0



    163.1



    350.4



    328.9

    Other



    107.6



    78.8



    211.2



    154.4

    Total Revenues



    1,532.5



    1,360.2



    3,020.4



    2,801.8

    Expenses

















    Compensation and benefits



    204.7



    205.7



    410.7



    410.2

    Technology



    64.1



    53.3



    123.5



    104.6

    Professional fees and outside services



    34.7



    37.8



    67.8



    76.1

    Amortization of purchased intangibles



    55.5



    57.0



    110.7



    113.8

    Depreciation and amortization



    28.7



    32.3



    58.8



    64.2

    Licensing and other fee agreements



    85.9



    78.2



    173.8



    162.9

    Other



    58.3



    57.3



    114.9



    117.7

    Total Expenses



    531.9



    521.6



    1,060.2



    1,049.5

    Operating Income



    1,000.6



    838.6



    1,960.2



    1,752.3

    Non-Operating Income (Expense)

















    Investment income



    1,044.5



    1,568.2



    2,115.8



    2,925.9

    Interest and other borrowing costs



    (40.1)



    (40.2)



    (80.0)



    (80.1)

    Equity in net earnings of unconsolidated subsidiaries



    86.4



    75.1



    173.6



    153.3

    Other non-operating income (expense)



    (936.9)



    (1,425.3)



    (1,901.7)



    (2,578.1)

    Total Non-Operating Income (Expense)



    153.9



    177.8



    307.7



    421.0

    Income before Income Taxes



    1,154.5



    1,016.4



    2,267.9



    2,173.3

    Income tax provision



    271.3



    238.8



    529.5



    511.9

    Net Income



    $      883.2



    $      777.6



    $  1,738.4



    $  1,661.4

    Net Income Attributable to Common Shareholders of CME

    Group



    $      872.1



    $      767.8



    $  1,716.5



    $  1,640.5



















    Earnings per Share Attributable to Common Shareholders of

    CME Group:

















    Basic



    $        2.43



    $        2.14



    $        4.78



    $        4.57

    Diluted



    2.42



    2.14



    4.77



    4.56

    Weighted Average Number of Common Shares:

















    Basic



    359,330



    358,940



    359,294



    358,937

    Diluted



    359,869



    359,429



    359,852



    359,371

     

    CME Group Inc. and Subsidiaries

    Quarterly Operating Statistics







    2Q 2023



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024

    Trading Days



    62



    63



    63



    61



    63

     

    Quarterly Average Daily Volume (ADV)(1)

    CME Group ADV (in thousands)



    Product Line



    2Q 2023



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024

    Interest rates



    11,273



    10,967



    13,348



    13,839



    12,894

    Equity indexes



    6,216



    6,353



    6,922



    6,856



    6,779

    Foreign exchange



    898



    942



    1,007



    984



    1,075

    Energy



    2,104



    2,126



    2,158



    2,412



    2,447

    Agricultural commodities



    1,752



    1,433



    1,469



    1,596



    1,877

    Metals



    612



    528



    609



    675



    868

    Total



    22,855



    22,349



    25,513



    26,360



    25,941

    Venue





















    CME Globex



    20,907



    20,838



    23,503



    23,985



    24,143

    Open outcry



    1,124



    713



    1,126



    1,333



    825

    Privately negotiated



    825



    797



    885



    1,043



    974

    Total



    22,855



    22,349



    25,513



    26,360



    25,941

     

    Quarterly Average Rate Per Contract (RPC)(1)

    CME Group RPC



    Product Line



    2Q 2023



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024

    Interest rates



    $         0.505



    $         0.508



    $         0.488



    $          0.486



    $         0.484

    Equity indexes



    0.644



    0.625



    0.616



    0.641



    0.628

    Foreign exchange



    0.800



    0.791



    0.806



    0.787



    0.754

    Energy



    1.347



    1.324



    1.338



    1.334



    1.297

    Agricultural commodities



    1.356



    1.328



    1.361



    1.356



    1.366

    Metals



    1.487



    1.492



    1.502



    1.556



    1.511

    Average RPC



    $         0.724



    $         0.707



    $         0.682



    $          0.695



    $         0.708



    1. ADV and RPC includes futures and options on futures only.

     

    CME Group Inc. and Subsidiaries

    Reconciliation of GAAP to non-GAAP Measures

    (dollars in millions, except per share amounts; shares in thousands)























    Quarter Ended

    June 30,



    Six Months Ended

    June 30,





    2024



    2023



    2024



    2023

    Net Income



    $       883.2



    $       777.6



    $  1,738.4



    $  1,661.4

    Restructuring and severance



    0.8



    1.6



    3.6



    2.3

    Amortization of purchased intangibles(1)



    68.9



    70.5



    137.6



    140.6

    Strategic transaction-related costs (credits)



    (1.1)



    —



    0.8



    (2.2)

    Real estate-related costs (credits)



    (1.0)



    —



    (1.0)



    —

    Foreign exchange transaction (gains) losses



    (0.3)



    1.1



    (2.1)



    1.8

    Unrealized and realized (gains) losses on investments



    (9.2)



    1.0



    (11.7)



    (73.8)

    Unrealized and realized (gains) losses on assets



    —



    0.4



    0.8



    0.4

    Income tax effect related to above



    (11.0)



    (15.0)



    (25.0)



    (11.0)

    Other income tax items



    1.9



    (0.8)



    1.9



    (0.8)

    Adjusted Net Income



    $       932.2



    $       836.4



    $  1,843.3



    $  1,718.7



















    Adjusted Net Income Attributable to Common Shareholders of CME Group



    $       920.4



    $       825.9



    $  1,820.1



    $  1,697.0



















    Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $         2.43



    $         2.14



    $        4.78



    $        4.57

         Diluted



    2.42



    2.14



    4.77



    4.56



















    Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $         2.56



    $         2.30



    $        5.07



    $        4.73

         Diluted



    2.56



    2.30



    5.06



    4.72



















    Weighted Average Number of Common Shares:

















         Basic



    359,330



    358,940



    359,294



    358,937

         Diluted



    359,869



    359,429



    359,852



    359,371

         Preferred shares(2)



    4,584



    4,584



    4,584



    4,584



    1. Includes $11.1 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.4 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC, reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

    2. Preferred shares have similar rights as common shares without voting rights.

     

    CME-G

    Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-all-time-record-revenue-of-1-5-billion-for-q2-2024--302204684.html

    SOURCE CME Group

    Get the next $CME alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    3/4/2026Buy → Hold
    Argus
    1/14/2026$305.00Hold → Buy
    TD Cowen
    10/23/2025$300.00Hold → Buy
    Deutsche Bank
    9/25/2025$300.00Neutral → Buy
    Citigroup
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    More analyst ratings

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CME Group downgraded by Argus

    Argus downgraded CME Group from Buy to Hold

    3/4/26 8:23:45 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded CME Group from Hold to Buy and set a new price target of $305.00

    1/14/26 8:20:33 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded CME Group from Hold to Buy and set a new price target of $300.00

    10/23/25 9:04:53 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CME Group Inc. Announces First-Quarter 2026 Earnings Release, Conference Call

    CHICAGO, March 11, 2026 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2026 before the markets open on Wednesday, April 22, 2026. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing t

    3/11/26 3:00:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Energy Complex Reaches All-Time Daily Volume Record of 8.3 Million Contracts

    CHICAGO, March 9, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its energy complex reached a new single-day volume record of 8.3 million contracts on March 6, surpassing the previous daily record of 7.9 million contracts set on March 3, 2026. "As geopolitical shifts drive uncertainty throughout the global energy sector, market participants are turning to CME Group to manage their risk," said Peter Keavey, Global Head of Energy Products at CME Group. "In these volatile market conditions, clients continue to rely on our liquid markets and benchmark products to discover prices, hedge and adjust exposure within their portfolios."Other highlight

    3/9/26 8:41:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Announces First Trades for South Asia Crude Palm Oil (Fastmarkets) Futures

    CHICAGO and SINGAPORE, March 9, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced a total of 100 contracts of the South Asia Crude Palm Oil (Fastmarkets) futures traded as a block between Avere Commodities and Olam Agri, brokered by ICAP, on March 5, 2026. CME Group launched its four new South Asia edible oil futures contracts, which are available for trading, on March 2, 2026. "We're pleased to see early industry support for our new South Asia edible oils futures contracts," said John Ricci, Managing Director and Global Head of Agricultural Products, CME Group. "The addition of these contracts provides South Asian market participants with enhanced

    3/8/26 10:00:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    SEC Filings

    View All

    SEC Form S-8 filed by CME Group Inc.

    S-8 - CME GROUP INC. (0001156375) (Filer)

    3/13/26 2:16:05 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form DEFA14A filed by CME Group Inc.

    DEFA14A - CME GROUP INC. (0001156375) (Filer)

    3/12/26 4:43:48 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form PRE 14A filed by CME Group Inc.

    PRE 14A - CME GROUP INC. (0001156375) (Filer)

    3/12/26 4:10:09 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Marcus Jonathan L

    4/A - CME GROUP INC. (0001156375) (Issuer)

    3/23/26 9:38:58 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Marcus Jonathan L

    4 - CME GROUP INC. (0001156375) (Issuer)

    3/19/26 9:47:13 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Sr MD Global Head Equity & FX Mccourt Timothy Francis was granted 5,504 units of Common Stock Class A and covered exercise/tax liability with 2,904 units of Common Stock Class A, increasing direct ownership by 27% to 12,108 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    3/17/26 12:24:10 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R bought $73,008 worth of Common Stock Class A (262 units at $278.37), increasing direct ownership by 0.45% to 2,477 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:30:36 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R bought $72,672 worth of Common Stock Class A (274 units at $265.19), increasing direct ownership by 0.47% to 2,466 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/26/25 8:46:02 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    6/26/25 6:11:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/24 5:02:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/23 2:49:27 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/11/22 3:04:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Financials

    Live finance-specific insights

    View All

    CME Group Inc. Announces First-Quarter 2026 Earnings Release, Conference Call

    CHICAGO, March 11, 2026 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2026 before the markets open on Wednesday, April 22, 2026. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing t

    3/11/26 3:00:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend

    CHICAGO, Feb. 12, 2026 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared its annual variable dividend and first-quarter regular dividend, both of which are payable March 26, 2026, to shareholders of record as of March 10, 2026: Annual variable dividend based on 2025 financial results of $6.15 per share totals approximately $2.2 billion.First-quarter regular dividend of $1.30 per share, a 5 cent increase from the prior level of $1.25 per share.Today's announced annual variable dividend based on 2025 financial results, when combined with quarterly dividends paid during 2025, will total approximately $4.0 billion, reflecting a total dividend yield of 4

    2/12/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

    Record annual revenue of $6.5 billion, up 6%Record annual market data revenue of $803 million, up 13%CHICAGO, Feb. 4, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2025. The company reported revenue of $1.6 billion and operating income of $1.0 billion for the fourth quarter of 2025. Net income was $1.2 billion and diluted earnings per common share were $3.24. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.77. Financial results presented on an adjusted basis for the fourth quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-G

    2/4/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Financial Institutions to Join BrokerTec Chicago for First Day of Trading

    New Central Limit Order Book for U.S. Treasury Trading to Launch Oct. 6CHICAGO, Sept. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Citigroup, J.P. Morgan and Morgan Stanley will be available to trade cash U.S. Treasuries on BrokerTec Chicago when it launches on October 6. "With leading financial firms on board for day one on BrokerTec Chicago, trading U.S. Treasury futures and cash will be more efficient than ever before," said Mike Dennis, CME Group Global Head of Fixed Income. "CME Group is in a unique position to bring these markets together, unlocking value for our clients worldwide who want to more precisely hedge their risk amid

    9/4/25 8:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

    CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

    5/9/25 10:29:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Clearing Appoints New Chief Risk Officer

    CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

    4/24/25 4:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance